Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MpoxVax Africa Study
PACTR202601855406764Recruiting
- Sponsor
- Makerere University Lung Institute
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Open-label, single-arm trial of JYNNEOS in mpox, sponsored by Makerere University Lung Institute. Primary endpoints: Mean geometric MVA-BN specific antibody titres from Week 6 to Week 48 and Mean rate of change in MVA-BN specific antibody titres from Week 6 to Week 48. Started Oct 2024; status: recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on PACTR202601855406764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601855406764.